Related Experiment Video
Updated: Nov 29, 2025
14:58
A Simplified Technique for In situ Excision of Cornea and Evisceration of Retinal Tissue from Human Ocular Globe
Published on: June 12, 2012
21.6K
Pterygium excision with modified bare sclera technique combined with mitomycin C
Yulia Aziza1,2, Tsutomu Inatomi3,4, Chie Sotozono1
1Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Hirokoji-agaru, Kawaramachi-dori, Kamigyo-ku, Kyoto, 602-0841, Japan.
Japanese Journal of Ophthalmology
|November 18, 2020
Summary
This study shows that a modified bare sclera technique with mitomycin C (MMC) is a safe and effective treatment for primary pterygium, with a low recurrence rate. The procedure offers good cosmetic results and minimal complications.
Area of Science:
- Ophthalmology
- Surgical Techniques
Background:
- Pterygium treatment involves various surgical methods with differing recurrence rates.
- Adjuvant mitomycin C (MMC) shows promise in reducing pterygium recurrence.
Purpose of the Study:
- To describe a modified bare sclera technique for pterygium excision.
- To evaluate the efficacy and safety of combining this technique with intraoperative MMC application.
Main Methods:
- A retrospective review of 32 primary pterygium eyes treated between January 2014 and December 2016.
- Utilized a modified bare sclera technique with intraoperative 0.04% MMC application, focusing on preventing MMC dilution and diffusion.
- Recorded surgical complications, recurrence rates, and onset.
Main Results:
- Mean follow-up was 26.4 months. No surgical complications were observed.
- Mean complete epithelialization occurred in 12.6 days.
- One case of recurrence was noted at 15 months in a patient with double-head primary pterygium.
Conclusions:
- The modified bare sclera technique with MMC is safe and effective for primary pterygium treatment.
- Strict adherence to safety protocols ensures good cosmetic outcomes.
- This method demonstrates a low recurrence rate for primary pterygium.
